Follow-Up of Men with Elevated Prostate-Specific Antigen and One Set of Benign Biopsies at Prostate Cancer Screening

By Zackrisson B.   Aus G.   Lilja H.   Lodding P.   Pihl C.-G.   Hugosson J.  

European Urology, Vol. 43, Iss. 4, 2003-04 ,pp. : 327-332

Elsevier

Access to resources Recommend Favorite

Prostate-specific antigen best practice policy-part II: prostate cancer staging and post-treatment follow-up

By Carroll P.   Coley C.   McLeod D.   Schellhammer P.   Sweat G.   Wasson J.   Zietman A.   Thompson I.  

Urology, Vol. 57, Iss. 2, 2001-02 ,pp. : 225-229

Elsevier

Access to resources Recommend Favorite

Nadir prostate-specific antigen as a predictor of progression to androgen-independent prostate cancer

By Benaim E.A.   Pace C.M.   Lam P.M.   Roehrborn C.G.  

Urology, Vol. 59, Iss. 1, 2002-01 ,pp. : 73-78

Elsevier

Access to resources Recommend Favorite

Limited suppression of prostate-specific antigen after salvage radiotherapy for its isolated elevation after radical prostatectomy

By Egawa S.   Matsumoto K.   Suyama K.   Soh S.   Kuwao S.   Iwamura M.  

Urology, Vol. 53, Iss. 1, 1999-01 ,pp. : 148-154

Elsevier

Access to resources Recommend Favorite

Impact of gastrojejunostomy diameter on long-term weight loss following laparoscopic gastric bypass: a follow-up study

By Smith Carter  

Surgical Endoscopy, Vol. 25, Iss. 7, 2011-07 ,pp. : 2164-2167

Springer Publishing Company

Access to resources Recommend Favorite